Migraine Headache as a Presenting Feature of Multiple Sclerosis: A Case Report

Multiple sclerosis (MS) is a chronic inflammatory disease, causing neuronal demyelination and axonal damage in the central nervous system. Symptoms of MS vary widely because of different grades of sensory, motor, and cognitive dysfunctions. Although headache as the initial symptom of MS is rare, it...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mohammad Mahdi Rabiei, Zahra Cheraghi, Mahtab Ramezani, Hossein Pakdaman
Formato:	article
Lenguaje:	EN
Publicado:	Shahid Beheshti University of Medical Sciences 2021
Materias:	migraine disorders headache multiple sclerosis treatment outcome Medicine R
Acceso en línea:	https://doaj.org/article/53a1a808cd0a4161955f9707fc6a2bc9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:53a1a808cd0a4161955f9707fc6a2bc9
record_format	dspace
spelling	oai:doaj.org-article:53a1a808cd0a4161955f9707fc6a2bc92021-11-16T10:51:31ZMigraine Headache as a Presenting Feature of Multiple Sclerosis: A Case Report2383-18712383-209610.34172/icnj.2021.41https://doaj.org/article/53a1a808cd0a4161955f9707fc6a2bc92021-10-01T00:00:00Zhttps://journals.sbmu.ac.ir/neuroscience/article/view/35542/27925https://doaj.org/toc/2383-1871https://doaj.org/toc/2383-2096Multiple sclerosis (MS) is a chronic inflammatory disease, causing neuronal demyelination and axonal damage in the central nervous system. Symptoms of MS vary widely because of different grades of sensory, motor, and cognitive dysfunctions. Although headache as the initial symptom of MS is rare, it is a common comorbidity that affects most patients. However, it is unclear that the headache manifestation in newly diagnosed people with MS should be considered as an MS attack or merely a comorbid condition. We report the case of a 31-year-old woman with newly diagnosed MS who presented with exacerbation of headache episodes without any abnormal neurological exam findings. The headaches did not respond to nonsteroidal anti-inflammatory drugs and triptans. After administration of methylprednisolone, the headaches were significantly improved, and during 3 months of follow-up receiving glatiramer acetate, no episode of headache has occurred. This case demonstrates the possible relationship between migraine and MS in newly diagnosed patients. New-onset headaches, a change in the pattern of previous episodes, and inadequate clinical drug response to headache treatment should all be taken seriously and warrant further investigation. Thereby, early diagnosis and proper treatment for patients with MS could improve their quality of life.Mohammad Mahdi RabieiZahra CheraghiMahtab RamezaniHossein PakdamanShahid Beheshti University of Medical Sciencesarticlemigraine disordersheadachemultiple sclerosistreatment outcomeMedicineRENInternational Clinical Neuroscience Journal, Vol 8, Iss 4, Pp 208-211 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	migraine disorders headache multiple sclerosis treatment outcome Medicine R
spellingShingle	migraine disorders headache multiple sclerosis treatment outcome Medicine R Mohammad Mahdi Rabiei Zahra Cheraghi Mahtab Ramezani Hossein Pakdaman Migraine Headache as a Presenting Feature of Multiple Sclerosis: A Case Report
description	Multiple sclerosis (MS) is a chronic inflammatory disease, causing neuronal demyelination and axonal damage in the central nervous system. Symptoms of MS vary widely because of different grades of sensory, motor, and cognitive dysfunctions. Although headache as the initial symptom of MS is rare, it is a common comorbidity that affects most patients. However, it is unclear that the headache manifestation in newly diagnosed people with MS should be considered as an MS attack or merely a comorbid condition. We report the case of a 31-year-old woman with newly diagnosed MS who presented with exacerbation of headache episodes without any abnormal neurological exam findings. The headaches did not respond to nonsteroidal anti-inflammatory drugs and triptans. After administration of methylprednisolone, the headaches were significantly improved, and during 3 months of follow-up receiving glatiramer acetate, no episode of headache has occurred. This case demonstrates the possible relationship between migraine and MS in newly diagnosed patients. New-onset headaches, a change in the pattern of previous episodes, and inadequate clinical drug response to headache treatment should all be taken seriously and warrant further investigation. Thereby, early diagnosis and proper treatment for patients with MS could improve their quality of life.
format	article
author	Mohammad Mahdi Rabiei Zahra Cheraghi Mahtab Ramezani Hossein Pakdaman
author_facet	Mohammad Mahdi Rabiei Zahra Cheraghi Mahtab Ramezani Hossein Pakdaman
author_sort	Mohammad Mahdi Rabiei
title	Migraine Headache as a Presenting Feature of Multiple Sclerosis: A Case Report
title_short	Migraine Headache as a Presenting Feature of Multiple Sclerosis: A Case Report
title_full	Migraine Headache as a Presenting Feature of Multiple Sclerosis: A Case Report
title_fullStr	Migraine Headache as a Presenting Feature of Multiple Sclerosis: A Case Report
title_full_unstemmed	Migraine Headache as a Presenting Feature of Multiple Sclerosis: A Case Report
title_sort	migraine headache as a presenting feature of multiple sclerosis: a case report
publisher	Shahid Beheshti University of Medical Sciences
publishDate	2021
url	https://doaj.org/article/53a1a808cd0a4161955f9707fc6a2bc9
work_keys_str_mv	AT mohammadmahdirabiei migraineheadacheasapresentingfeatureofmultiplesclerosisacasereport AT zahracheraghi migraineheadacheasapresentingfeatureofmultiplesclerosisacasereport AT mahtabramezani migraineheadacheasapresentingfeatureofmultiplesclerosisacasereport AT hosseinpakdaman migraineheadacheasapresentingfeatureofmultiplesclerosisacasereport
_version_	1718426545045897216

Migraine Headache as a Presenting Feature of Multiple Sclerosis: A Case Report

Ejemplares similares